How Dr. Ted Love Sold His Sickle Cell Company To Pfizer For $5.4 Billion

Written By Shimite Obialo

Chronicling Dr. Ted Love's CEO journey in biotech and the sale of his sickle cell company Global Blood Therapeutics which Pfizer acquired in August 2022 for $5.4 billion

https://www.forbes.com/sites/shimiteobialo/2024/02/05/how-dr-ted-love-sold-his-sickle-cell-company-to-pfizer-for-54-billion/

Shimite Obialo
Previous

‘Hot Chicken’ Is On The Menu With Dave’s Billion Dollar Buyout
Next

A Multi-Million Dollar Mess: Gathering Spot Faces-Off With Greenwood